C

Community Cancer Trials of Utah | Ogden, UT

Research site
(Unclaimed)
Location
5290 S 400 E, Ogden, Utah, United States of America
Site insights

Top conditions

Leukemia (5 trials)

Breast Cancer (4 trials)

Primary Myelofibrosis (3 trials)

Myeloid Leukemia (3 trials)

Thrombocytopenia (3 trials)

Top treatments

Bendamustine
Ianalumab
Cyclophosphamide
Loperamide
Zandelisib
Doxorubicin
Osimertinib
Ruxolitinib
Pembrolizumab
Trastuzumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

19 of 27
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera (VERIFY)

The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and...

Enrolling
Polycythemia Vera
Drug: Placebo
Drug: Rusfertide

The drug that will be investigated in the study is an antibody, epcoritamab, also known as EPKINLY™ and GEN3013. Since the safety and tolerability of...

Active, not recruiting
Diffuse Large B-cell Lymphoma
Drug: Investigator's Choice Chemotherapy
Biological: Epcoritamab

The purpose of the study is to evaluate the overall survival of participants treated with imetelstat compared to best available therapy with intermed...

Enrolling
Myelofibrosis
Drug: Imetelstat
Drug: Best Available Therapy (BAT)

This is a Phase 2 open-label, multicenter study evaluating tolerability and efficacy of navitoclax alone or when added to ruxolitinib in participants...

Active, not recruiting
Myelofibrosis (MF)
Drug: Navitoclax
Drug: Ruxolitinib

The purpose of this study is to evaluate the effect of two different doses of ianalumab added to eltrombopag to prolong Time to Treatment Failure (TT...

Enrolling
Primary Immune Thrombocytopenia
Biological: Ianalumab
Drug: Eltrombopag

The purpose of this study is to evaluate efficacy of erdafitinib versus chemotherapy or pembrolizumab in participants with advanced urothelial cancer...

Active, not recruiting
Urothelial Cancer
Drug: Erdafitinib
Drug: Vinflunine

This randomized, double-blind, placebo-controlled, two-arm study will assess the safety and efficacy of pertuzumab in addition to chemotherapy plus t...

Active, not recruiting
Breast Cancer
Drug: 5-Fluorouracil
Drug: Trastuzumab

This study will assess the antitumor activity, safety, tolerability, and pharmacokinetics (PK) of the Mesenchymal-epithelial Transition Factor (MET)...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Osimertinib
Drug: Tepotinib

This study will evaluate the efficacy and safety of venetoclax and obinutuzumab (VEN + G) compared with fludarabine + cyclophosphamide + rituximab or...

Active, not recruiting
Chronic Lymphocytic Leukemia (CLL)
Drug: Fludarabine
Drug: Cyclophosphamide

The purpose of this study is to evaluate the efficacy and safety of ibrutinib + venetoclax (I+V) and ibrutinib monotherapy regimens in which dosing o...

Enrolling
Small Lymphocytic Lymphoma
Leukemia, Lymphocytic, Chronic, B-Cell
Drug: Venetoclax
Drug: Ibrutinib

This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously u...

Enrolling
Follicular Lymphoma (FL)
Drug: Odronextamab
Drug: Vincristine

This will be a multicenter Phase II open-label study of asciminib in CML-CP patients who have been previously treated with one prior ATP- binding sit...

Enrolling
Chronic Myelogenous Leukemia - Chronic Phase
Drug: asciminib

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their cancer:cannot be...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

The main purpose of the study was to investigate whether nilotinib treatment can be safely suspended with no recurrence of CML in selected patients w...

Active, not recruiting
Chronic Myelogenous Leukemia
Drug: Nilotinib followed by treatment-free

The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors an...

Active, not recruiting
Solid Tumor
Locally Advanced Solid Tumor
Drug: Niraparib

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic in...

Enrolling
Solid Tumor
Malignant Neoplasm
Drug: nab-sirolimus

The purpose of this study is to evaluate the effect of two different doses of ianalumab versus placebo in addition to first-line corticosteroids in m...

Enrolling
Primary Immune Thrombocytopenia (ITP)
Drug: Corticosteroids
Biological: Ianalumab
Locations recently updated

To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer, or br...

Enrolling
Chemotherapy-induced Thrombocytopenia
Drug: Romiplostim
Drug: Placebo

This trial will include 2 portions (phase 1 and phase 2).The first portion will be a Phase I, open label, dose escalation study to establish the maxi...

Active, not recruiting
Pancreatic Cancer
Biological: XB2001 or Placebo

Trial sponsors

Novartis logo

Novartis (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems